Evidence map›Paper›PMID 21606163›Full record

ArticleHaematologica2011

The DNA binding factor Hmg20b is a repressor of erythroid differentiation.

Fatemehsadat Esteghamat, Thamar Bryn van Dijk, Harald Braun, Sylvia Dekker, Reinier van der Linden, Jun Hou, Pavlos Fanis, Jeroen Demmers, Wilfred van IJcken, Zeliha Ozgür and 4 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Strategies that regulate LSD1 for novel therapeutics.Acta pharmaceutica Sinica. B · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Fatemehsadat EsteghamatDepartment of Cell Biology, Erasmus MC, Rotterdam, The Netherlands.
Thamar Bryn van Dijk
Harald Braun
Sylvia Dekker
Reinier van der Linden
Jun Hou
Pavlos Fanis
Jeroen Demmers
Wilfred van IJcken
Zeliha Ozgür
Rastislav Horos
Farzin Pourfarzad
Marieke von Lindern
Sjaak Philipsen
Erasmus MC · NLSanquin · NLStem Cell Institute · PA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn erythroblasts, the CoREST repressor complex is recruited to target promoters by the transcription factor Gfi1b, leading to repression of genes mainly involved in erythroid differentiation. Hmg20b is a subunit of CoREST, but its role in erythropoiesis has not yet been established. DESIGN AND

methodsTo study the role of Hmg20b in erythropoiesis, we performed knockdown experiments in a differentiation-competent mouse fetal liver cell line, and in primary mouse fetal liver cells. The effects on globin gene expression were determined. We used microarrays to investigate global gene expression changes induced by Hmg20b knockdown. Functional analysis was carried out on Hrasls3, an Hmg20b target gene.

resultsWe show that Hmg20b depletion induces spontaneous differentiation. To identify the target genes of Hmg20b, microarray analysis was performed on Hmg20b knockdown cells and controls. In line with its association to the CoREST complex, we found that 85% (527 out of 620) of the deregulated genes are up-regulated when Hmg20b levels are reduced. Among the few down-regulated genes was Gfi1b, a known repressor of erythroid differentiation. Among the consistently up-regulated targets were embryonic β-like globins and the phospholipase HRAS-like suppressor 3 (Hrasls3). We show that Hrasls3 expression is induced during erythroid differentiation and that knockdown of Hrasls3 inhibits terminal differentiation of proerythroblasts.

conclusionsWe conclude that Hmg20b acts as an inhibitor of erythroid differentiation, through the down-regulation of genes involved in differentiation such as Hrasls3, and activation of repressors of differentiation such as Gfi1b. In addition, Hmg20b suppresses embryonic β-like globins.

Indexed as

AnimalsCell Cycle ProteinsCell Line, TumorCells, CulturedCo-Repressor ProteinsDNA-Binding ProteinsErythroid CellsErythropoiesisGene Expression ProfilingGene Expression Regulation, DevelopmentalGene Knockdown TechniquesHeLa CellsHigh Mobility Group ProteinsHumansMiceMultiprotein ComplexesCell Cycle ProteinsCo-Repressor ProteinsDNA-Binding ProteinsGfi1b protein, mouseHigh Mobility Group ProteinsHmg20b protein, mouseMultiprotein ComplexesNerve Tissue ProteinsPhospholipases A2, Calcium-IndependentPlaat3 protein, mouseProto-Oncogene ProteinsRcor2 protein, mouseRepressor Proteins

Identifiers

PMID21606163
PMCPMC3166094
OpenAlexW2076349428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.